• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Liquidia Corp (NQ: LQDA )

    10.27 -0.36 (-3.39%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Liquidia Corp

    < Previous 1 2 3 4 5 Next >
    Jim Cramer Praises PayPal CEO Alex Chriss: 'Financial Techs Have Come Back In Style'
    PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more. 
    Via Benzinga
    Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
    Via Benzinga
    Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Liquidia Corporation Shares Are Moving Lower Monday
    Liquidia announced that the Food and Drug Administration granted tentative approval of YUTREPIA. 
    Via Benzinga
    Expert Ratings For Liquidia
    Via Benzinga
    Earnings Scheduled For November 13, 2024
    Via Benzinga
    Uncovering Potential: Liquidia's Earnings Preview
    Via Benzinga
    Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Evaluating Liquidia: Insights From 14 Financial Analysts
    Via Benzinga
    Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
    Via Benzinga
    Exposures Fossil Fuels
    Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    These Analysts Cut Their Forecasts On Liquidia
    Via Benzinga
    Expert Outlook: Liquidia Through The Eyes Of 5 Analysts
    Via Benzinga
    Forecasting The Future: 5 Analyst Projections For Liquidia
    Via Benzinga
    Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
    The company is hoping to launch a drug that rivals United Therapeutics' Tyvaso DPI. 
    Via Investor's Business Daily
    Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q2 2024
    LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    7 Analysts Have This To Say About Liquidia
    Via Benzinga
    Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
    Via Benzinga
    The Analyst Landscape: 5 Takes On Liquidia
    Via Benzinga
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
    Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics. 
    Via Investor's Business Daily
    Topics Intellectual Property
    Exposures Intellectual Property
    Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024
    LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
    "Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got big selling going on in AI stock Meta," he added. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.